Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
CPT Pharmacometrics Syst Pharmacol
.
2019 Jul;8(7):440-443.
doi: 10.1002/psp4.12418.
Epub 2019 Jun 5.
Authors
Ayyappa Chaturvedula
1
,
Stacie Calad-Thomson
2
,
Chao Liu
3
,
Mark Sale
4
,
Nandu Gattu
5
,
Navin Goyal
6
Affiliations
1
UNT University of North Texas System College of Pharmacy, UNTHSC University of North Texas Health Science Center, Fort Worth, Texas, USA.
2
ATOM Accelerating Therapeutics for Opportunities in Medicine Consortium, GlaxoSmithKline, San Francisco, California, USA.
3
Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, Maryland, USA.
4
Nuventra, Raleigh, North Carolina, USA.
5
Excelra, Hyderabad, India.
6
Clinical Pharmacology, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
PMID:
31006175
PMCID:
PMC6657004
DOI:
10.1002/psp4.12418
No abstract available
MeSH terms
Algorithms
Artificial Intelligence
Drug Design
Humans
Models, Theoretical
Pharmacology, Clinical / methods*
Systems Biology